Skip to main content

Wealthfront Advisers LLC

SEC CIK
0001763921
Latest filing
Aug 7, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
76,210
Value
$3.25M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BSX by Wealthfront Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202676,210$3.25M<0.1%−22,894−23.1%ReducedHolders
Q1 202699,104$6.22M<0.1%−27,180−21.5%ReducedHolders
Q4 2025126,284$12.0M<0.1%−20,222−13.8%ReducedHolders
Q3 2025146,506$14.3M<0.1%−1,589−1.1%ReducedHolders
Q2 2025148,095$15.9M<0.1%+6,902+4.9%AddedHolders
Q1 2025141,193$14.2M<0.1%+27,075+23.7%AddedHolders
Q4 2024114,118$10.2M<0.1%+7,338+6.9%AddedHolders
Q3 2024106,780$8.95M<0.1%+3,032+2.9%AddedHolders
Q2 2024103,748$7.99M<0.1%+4,425+4.5%AddedHolders
Q1 202499,323$6.80M<0.1%+2,520+2.6%AddedHolders
Q4 202396,803$5.60M<0.1%+7,917+8.9%AddedHolders
Q3 202388,886$4.69M<0.1%+5,887+7.1%AddedHolders
Q2 202382,999$4.49M<0.1%+17,659+27.0%AddedHolders
Q1 202365,340$3.27M<0.1%+7,920+13.8%AddedHolders
Q4 202257,420$2.66M<0.1%−4,371−7.1%ReducedHolders
Q3 202261,791$2.39M<0.1%+24,002+63.5%AddedHolders
Q2 202237,789$1.41M<0.1%−929−2.4%ReducedHolders
Q1 202238,718$1.71M<0.1%+3,307+9.3%AddedHolders
Q4 202135,411$1.50M<0.1%−144−0.4%ReducedHolders
Q3 202135,555$1.54M<0.1%+4,476+14.4%AddedHolders
Q2 202131,079$1.33M<0.1%+3,660+13.3%AddedHolders
Q1 202127,419$1.06M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.